Tilt test in paced patients: Is it worth the effort?  by Bhargava, Kartikeya
w.sciencedirect.com
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u r n a l 1 5 ( 2 0 1 5 ) 1 8 9e1 9 2HOSTED BY Available online at wwScienceDirect
journal homepage: www.elsevier .com/locate/ IPEJTilt test in paced patients: Is it worth the effort?Introduction
Syncope is an important symptom that though most
commonly benign, deserves extensive evaluation since it can
also be caused at times by life threatening causes that are
potentially treatable. An important cause of syncope is
symptomatic bradycardia either due to sick sinus syndrome
or atrioventricular block that is treated easily by pacemaker
therapy. However, the most common cause of syncope in
patients with normal heart is vasovagal or neurocardiogenic
syncope where pacemaker therapy has a very limited role.
When syncope recurs in a patient who received the pacing
therapy for the same symptom, it not only becomes very
difficult to explain to the patient but also poses significant
diagnostic challenges.
Head-up tilt test (HUTT) has been in use for evaluation of
patients with suspected recurrent vasovagal syncope for
many decades. However, data regarding its use in patients
with pacing devices is scanty. Hence, the study by Haarmark
et al. in this issue of the journal [1], reporting the results of
HUTT in patients with pacemakers and recurrent syncope is
a welcome addition to the literature. Though, the authors
suggest that a positive HUTT even in a patient with pace-
maker indicates a diagnosis of vasovagal syncope implying a
benign condition, syncope in paced patients and role of
HUTT in its evaluation has to be interpreted in the right
perspective. The following discussion points may help in this
regard.Is syncope seen in patients with pacemakers
despite normal pacing system function?
Syncope or similar symptoms after implantation of pace-
makers (or other cardiac implantable devices) is not as un-
common as is thought despite a clear cause and standard
indication of pacing. The incidence may depend on the indi-
cation of implant - lowest when the indication was symp-
tomatic atrioventricular block in structurally normal heart,Peer review under responsibility of Indian Heart Rhythm Society.highest when the indication was primarily vasovagal syncope
and in between in patients with sick sinus syndrome where it
may be seen in up to 17.5% of patients [2e5].
The etiology of syncope in paced patients is variable and
may include vasovagal syncope, postural hypotension, drug
induced hypotension, ventricular arrhythmias, acute
myocardial ischemia and last but not the least pacing system
malfunction [6].
When syncope occurs in a patient with pacemaker, one is
tempted to believe that a malfunction in the pacemaker or
the lead/s is responsible for the recurrence of symptoms. It
may actually be true when the syncope occurs early after
implant and the abnormality and likely cause of it is usually
obvious on pacemaker interrogation. However, when the
time to recurrent syncope is long after implant, contrary to
the popular belief, pacing malfunction is seen only in a small
percentage (less than 10%) of patients [4,6]. Hence, these
patients need extensive evaluation as in patients without
pacemaker and diagnosis remains quite challenging. A defi-
nite cause remains elusive in a large percentage (up to 30%)
of patients with syncope occurring after pacemaker im-
plantation [3,6].Are there identifiable predictors of syncope in
paced patients?
The predictors of syncope in paced patients includes ex-
tremes of age (<40 years and >80 years) [2], previous history
of syncope [2,3], past history of myocardial infarction or
heart failure and presence of co-morbidities [2]. Among non-
paced patients, vasovagal syncope is the most common
cause of syncope in young patients whereas in elderly pa-
tients cardiac causes, drug induced and postural hypoten-
sion are the predominating causes [7]. All these age-related
causes may not be or only partially helped with pacing and
hence similar etiologies may exist even in paced patients at
the extremes of age.
History of syncope prior to pacing is a strong predictor of
syncope in paced patient and suggests that co-existing etiol-
ogy, for example vasovagal, may be responsible for syncope
although pacing was performed for an already established
indication like sick sinus syndrome [3].
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predict the occurrence of syncope?
Single chamber AAI/R pacing in patients with sick sinus syn-
drome with intact atrioventricular conduction has been the
preferred choice in most recommendations and guidelines [8]
of pacing despite the fact that most implanters across the
globe prefer to implant dual-chamber pacemakers in such
situations. The presence of known risk, though small, of
development of atrioventricular block over time in these pa-
tients and the development of pacing algorithms that prevent
unnecessary right ventricular pacing has been used as the
justification for dual-chamber pacing by these implanters.
The recent European guidelines [9] of pacing, in fact have now
recommended dual-chamber pacing with AV delay manage-
ment as the first choice in patients with sick sinus syndrome
(with AAI/R pacing as second choice) based on the results of
the DANPACE trial [10].
Still based on old recommendations, many patients still
have AAI/R pacemakers and may develop syncope due to
development of AV block. In the sub-study of DANPACE trial
[2], 21 of the 54 patients who required upgradation to a dual-
chamber system experienced syncope. However, the repeat
data analysis after excluding these 54 patients revealed
similar incidence and predictors of syncope post pacemaker
implant. Similar to this fact, one should remember that as in
the report by Haarmark et al. [1], syncope in patients with AAI/
R may be due to coexisting vasovagal syndrome rather than
development of AV block. It may be worthwhile explaining
these issues to the patient before upgrading the device in the
absence of documented AV block.
Whether syncope is more likely to occur in patients paced
for sick sinus syndrome than for AV block has not been
evaluated. Although unexplained syncope in patients when
the indication of pacing is AV block is quite rare [5], co-existing
vasovagal syncope may be responsible for occurrence of
syncope in these patients. Interestingly, in the current report
by Haarmark et al. [1], pacing indication was not statistically
different between HUTT positive and negative patients with
syncope after pacing.Why is the incidence of positive HUTT higher in
pacemaker patients with syncope?
The current study by Haarmark et al. [1] showed that 54% of
patients with pacing devices and syncope or presyncope had a
positive response to HUTT that is much higher than the
response seen in non-paced patients. Does it suggest that the
paced patients have a higher chance of having vasovagal
syncope or is due to other reasons? The patients with pace-
maker and syncope are a highly selected population in which
bradyarrhythmia as a cause of syncope is automatically
excluded provided the pacing system function is normal. Also,
since most pacemakers record high atrial and ventricular rate
episodes, tachyarrhythmia as a cause of syncope will be
evident on pacemaker interrogation. Moreover, it is very likely
that these patients underwent complete evaluation for syn-
cope prior to pacemaker implant and hence any significantstructural heart disease likely to result in syncope would have
already been excluded. Hence, in this patient population only
few remaining causes of syncope are plausible, of which
vasovagal syncope is the most likely cause. It is not surprising
therefore, that these patients have a higher positivity rate
during HUTT.Does a positive HUTT indicate a diagnosis of
vasovagal syncope in these patients and does it
have a clinical utility?
HUTT is in clinical use for evaluation of patients with syncope
for almost three decades with the belief that a positive result
indicates a diagnosis of vasovagal syncope. However, recently
there has been skepticism in its clinical utility due to variable
sensitivity and specificity and inability to help in the diagnosis
in situations where other modalities have failed to make a
diagnosis. That is, it helps in the diagnosis of vasovagal syn-
cope with good sensitivity and specificity in individuals where
the diagnosis is already apparent on workup but in patients
with initially unexplained syncope it shows many false posi-
tive (proven to be arrhythmic later) [11] or false negative (un-
diagnosed after full workup and likely vasovagal) results [12].
The scenario is not likely to be different in paced patients with
syncope.
This has lead to a new different interpretation of HUTT
wherein a positive result on HUTT is believed to indicate a
hypotensive susceptibility to the passive postural stress
rather than a diagnosis of vasovagal syncope [13]. This hy-
pothesis also explains why some patients (who have the hy-
potensive susceptibility and hence a positive HUTT) with a
particular arrhythmia (or any other possible etiology of syn-
cope) have syncope whereas others do not. Thus, according to
this interpretation of HUTT, a positive result with HUTT sug-
gests the presence of hypotensive susceptibility that plays a
role in causing syncope irrespective of the etiology and
mechanism of syncope [13].
Extrapolating the same thinking to patients with syncope
who already have a pacemaker, and in whom cardiac
arrhythmia as a cause of syncope is unlikely (bradycardia
unlikely with normal pacemaker functioning and tachyar-
rhythmia excluded by pacemaker diagnostics), a positive
HUTT will suggest the presence of hypotensive susceptibility
that is not corrected by pacing. In this patient population, it
may be suggestive but not diagnostic of vasovagal syncope
with a strong vasodepressor component and also explains
high positivity rate of HUTT. On the other hand, a negative
HUTT will not rule out a diagnosis of vasovagal syncope and
will not help in diagnosis. Hence, the clinical utility of HUTT
for diagnosing the cause of syncope will be limited in pace-
maker patients presenting with syncope.Does HUTT help in guiding pacemaker therapy in
patients with vasovagal syncope?
Though the initial studies suggested that pacemaker therapy
may be beneficial in some patients with vasovagal syncope,
the randomized studies have shown inconsistent results with
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younger (<40 years) patients with vasovagal syncope almost
never benefit from pacing. Some elderly patients who have
documented prolonged asystole or pauses during sponta-
neous syncope do show benefit with pacing as was seen in the
ISSUE-3 trial [14]. A substudy of ISSUE-3 trial showed that the
patients whowere HUTT positive and treatedwith pacemaker
therapy had a very high recurrence of syncope similar to pa-
tients that were not treated. In contrast, the patients with
asystole (on prolonged ECG monitoring) during spontaneous
syncope who were HUTT negative had very low recurrence of
syncope and were the most likely to benefit from pacing [15].
Thus, this substudy again suggested that a positive HUTT
results indicates hypotensive susceptibility and may predict
lack of benefit with pacing whereas a negative HUTT in a pa-
tient with documented asystole during spontaneous syncope
may guide towards pacemaker therapy.
A positive HUTT in patients with syncope who already
have a pacemaker may again suggest hypotensive suscepti-
bility and also confirms the finding of ISSUE-3 substudy
regarding the lack of benefit of pacing if the primary reason for
the implantwas vasovagal syncope. A positive HUTTmay also
guide withdrawal or dose reduction of antihypertensive or
vasodilator medications in these patients as a part of treat-
ment. Though, few studies have suggested that these medi-
cations may enhance the hypotensive susceptibility during
HUTT, whether their withdrawal can help in improving clin-
ical outcomes in HUTT positive patients with syncope re-
mains to be studied.Can HUTT help in assessing the prognosis of
pacemaker patients with syncope?
The patients with pacemaker or other devices who have
syncope have a worse prognosis and higher mortality as has
been seen in theDANPACE study [2]. Even in the SCDHEFT trial
comparing implantable defibrillator, amiodarone and placebo
among patients with left ventricular dysfunction, occurrence
of syncope was associated with increased mortality in all the
three groups [16]. Though, conditions like vasovagal syncope
and pacemaker treated sick sinus syndrome are considered
benign, syncope due cardiac causes or arrhythmias have a
worse prognosis. But interestingly, syncope in patients treated
for these conditions with device therapy is still associated
with increased mortality indicating that syncope is just a
surrogate marker of mortality risk that is primarily deter-
mined by the underlying heart disease and associated co-
morbid conditions. The study by Haarmark et al. in this
issue of the journal [1] has not looked in to the prognosis of
patients with syncope but it will be interesting to see whether
the result of HUTT is a predictor of mortality in patients with
pacemaker who have syncope.Conclusions
The present study along with the scanty existing literature
indicates that syncope is not uncommon in patients with
pacemakers. The etiology of syncope in these patients isvariable and diagnosis often challenging. Though, pacing
system malfunction is logically the most obvious cause, it is
rare and easily identifiable. HUTT may show a positive
response more commonly in paced patients, as also seen in
the study published in this issue, suggesting a diagnosis of
vasovagal syncope as a coexisting etiology. However, it should
be interpreted in the right perspective and with the under-
standing that a positive test may merely suggest hypotensive
susceptibility rather than the diagnosis. Whether HUTT can
help in guiding treatment by withdrawing antihypertensive
medications needs to be studied in large scale trials.Conflict of interest
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